<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1360040</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Immunometabolism applied to exercise, nutrition and pharmacology treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lira</surname>
<given-names>F&#xe1;bio Santos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/328056"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosa-Neto</surname>
<given-names>Jos&#xe9; Cesar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/508931"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Turner</surname>
<given-names>James Edward</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/446155"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Exercise and Immunometabolism Research Group, Post-graduation Program in Movement Sciences, Department of Physical Education, Universidade Estadual Paulista (UNESP)</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centro de Investiga&#xe7;&#xe3;o em Desporto e Atividade F&#xed;sica (CIDAF), University of Coimbra</institution>, <addr-line>Coimbra</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Cell and Developmental Biology, Immunometabolism Research Group, Institute of Biomedical Sciences, University of Sao Paulo (USP)</institution>, <addr-line>Sao Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Willem Van Eden, Utrecht University, Netherlands</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: F&#xe1;bio Santos Lira, <email xlink:href="mailto:fabio.lira@unesp.br">fabio.lira@unesp.br</email>; Jos&#xe9;&#xa0;Cesar Rosa-Neto, <email xlink:href="mailto:jrosaneto@usp.br">jrosaneto@usp.br</email>; James Edward Turner, <email xlink:href="mailto:j.e.turner.2@bham.ac.uk">j.e.turner.2@bham.ac.uk</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1360040</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Lira, Rosa-Neto and Turner</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Lira, Rosa-Neto and Turner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/51288" ext-link-type="uri">Editorial on the Research Topic <article-title>Immunometabolism applied to exercise, nutrition and pharmacology treatment</article-title>
</related-article>
<kwd-group>
<kwd>immunometabolism</kwd>
<kwd>exercise</kwd>
<kwd>nutrition</kwd>
<kwd>immune cells</kwd>
<kwd>pharmacology</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="2"/>
<page-count count="3"/>
<word-count count="709"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Nutritional Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Examining the energetic metabolism of immune cells is not a recent development (<xref ref-type="bibr" rid="B1">1</xref>) but the field of &#x2018;immunometabolism&#x2019; has rapidly expanded over the past decade (<xref ref-type="bibr" rid="B2">2</xref>). A growing area within immunometabolism examines the influence nutrients and energetic substrates have in regulating the functions of immune cells, often in the context of metabolic disruption and systemic inflammation. Ageing and several chronic conditions, including obesity, type 2 diabetes, dyslipidemia and auto-immune inflammatory diseases require further investigation to examine how immunometabolism influences pathophysiology and the molecular mechanisms governing cell metabolism. Exercise and nutrition interventions are commonly employed to improve metabolic and inflammatory profiles and to counter the pathophysiology of chronic disease, but interaction with immunometabolism is understudied. The present Research Topic, includes immunometabolism studies undertaken in the context of exercise, nutrition and pharmacological treatment of chronic inflammatory disease.</p>
<p>Studies have shown that eating an olive oil-containing Mediterranean diet &#x2013; comprising high levels of mono-unsaturated fatty acids &#x2013; is associated with a variety of health benefits. In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1213026">D&#xf6;ding et&#xa0;al.</ext-link> compared the impact of a mono-unsaturated fatty acid enriched diet to a saturated fatty acid enriched diet on bone metabolism, bone microarchitecture and inflammation in the context of experimental <italic>P. gingivalis</italic> infection in mice. A saturated fatty acid enriched diet reduced systemic bone microarchitecture and increased lipotoxic metabolites but these changes could be reversed by a mono-unsaturated fatty acid enriched diet.</p>
<p>In the setting of pharmacological treatment of chronic inflammatory disease, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1179877">Peng et&#xa0;al.</ext-link> demonstrated using single-cell sequencing that upregulation of ascorbate and aldarate metabolism, as well as fatty acid degradation, enhances the immunosuppressive capacity of regulatory T cells in patients with psoriatic arthritis and limits the pro-inflammatory action of central memory and effector memory T cells. The authors suggest that ascorbic acid and fatty acid metabolic pathways may be an adjunctive reprogramming strategy with adalimumab and etanercept &#x2013;biological therapies targeting tumour necrosis factor-alpha (TNF-&#x3b1;).</p>
<p>It is known that both redox responses to exercise bouts and metabolic responses to glucose ingestion exhibit individual variation. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1127088">Thomas et&#xa0;al.</ext-link> combine this knowledge to examine whether responses to acute high glucose ingestion are influenced by a bout of exercise performed 3 or 24 hours before. Several oxidative stress biomarkers and antioxidant measurements increased immediately after exercise, returning towards pre-exercise values within 3 hours. Redox responses to glucose ingestion depended on the biomarker and timepoint examined. The magnitude and direction of change was variable between individuals and the pattern of change was partly influenced by the timing of exercise before glucose ingestion. Thus, this study highlights the importance of presenting individual data and controlling for exercise in the hours or days prior to redox and metabolic measurements.</p>
<p>Finally, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1212745">Silva et&#xa0;al.</ext-link> explored the potential influence of physical activity levels on systemic and cellular immunometabolic measurements in young adults after mild-to-moderate COVID-19. Higher physical activity was partially associated with better metabolic and inflammatory profiles in the serum of post-COVID-19 patients. In addition, higher physical activity was associated lower expression of PD-1 in CD8+ T cells and lower TNF-&#x3b1; and IL-6 production by LPS- and PMA-stimulated peripheral blood mononuclear cells. As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, the yellow face represents exhausted immune cells, which might be related to hyperactivation during COVID-19, leading to dysregulated cytokine production. The cyclones next to the image of PBMCs and tube of blood represent higher/lower cytokine production by PBMCs or higher/lower cytokines in serum. These changes were partially protected by Physical Activity Level.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Young people post-infected with SARS-CoV-2 exhibited an exhaustive profile and anaerobic metabolism in PBMCs, and Physical Activity Level protects intracellular changes partially. IL-6, Interleukin 6; IL-10, Interleukin 10; TNFRS, Soluble TNF-&#x3b1; receptor; PGE<sub>2</sub>, Prostaglandin E2; TG, Triglyceride; PBMC, Peripheral blood mononuclear cell; T Cells, T lymphocytes; PD-1, Programmed death protein-1; Leak, Complex I respiration mitochondrial; CI OXPHOS; Complex I Oxidative phosphorylation respiration mitochondrial; LPS, Lipopolysaccharide; PMA, Phorbol 12-myristate 13-acetate; &#x2295;, Increased; &#x2296;, Decreased. Red text indicates a protective effect of physical activity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1360040-g001.tif"/>
</fig>
<p>Taken together, this Research Topic highlights important interaction between nutrients, physical activity, exercise and pharmacological treatment of inflammatory disease with systemic and cellular immunometabolic profiles.</p>
</sec>
<sec id="s2" sec-type="author-contributions">
<title>Author contributions</title>
<p>FL: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. JR-N: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. JT: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s4" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s5" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ebeling</surname> <given-names>AH</given-names>
</name>
</person-group>. <article-title>THE FUNDAMENTAL PROPERTIES OF THE FIBROBLAST AND THE MACROPHAGE: I</article-title>. <source>THE FIBROBLAST. J Exp Med</source> (<year>1926</year>) <volume>44</volume>(<issue>2</issue>):<page-range>261&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.44.2.261</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathis</surname> <given-names>D</given-names>
</name>
<name>
<surname>Shoelson</surname> <given-names>SE</given-names>
</name>
</person-group>. <article-title>Immunometabolism: an emerging frontier</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>(<issue>2</issue>):<fpage>81</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2922</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>